Home
xeomin

xeomin Market Share Analysis for August 2026

xeomin® is a uniquely purified choice for movement disorders or frown lines. find out more information about xeomin® if you are a patient or healthcare professional.

Health > Pharmacy

Domainxeomin.com

Year Founded2005

Employees51 - 200

Annual Revenue$100M - $200M

xeomin

xeomin (including company regionals)

xeomin.com

See more website traffic and engagement information

xeomin Revenue up to August 2026 is 100M - 200M

revenue generated by xeomin top domains

xeomin top domains revenue over 3 years

Revenue for xeomin top domains

xeomin.com100M - 200M

See more with Sales Intelligence

Total visits to xeomin's top domains

Understand xeomin market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

xeomin.com323.9K

See more with Sales Intelligence

Avg. visit duration in xeomin's top domains

Analyze xeomin engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

xeomin.com00:01:07

See more with Sales Intelligence

Avg. pageviews on xeomin's top domains

See how xeomin keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

xeomin.com1.33

See more with Sales Intelligence

xeomin top competitors by domain

Top similar sites in August 2026, ranked by their affinity

merzusa.comCompany NameMerz North AmericaEmployees501 - 1000HQUnited States, North Carolina, RaleighAnnual revenue$5M - $10MTotal visits3.9KHealth

Top technologies used by xeomin

These are the website technologies, by industry, used by xeomin top domains

Advertising (11)

DoubleClick

Conversion & Analytics (3)

Google Analytics

Payment & Currencies (3)

Visa

Widget (3)

Twemoji

More Technologies

8

See all

News & Signals from xeomin

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsDaxxify identified as competitor of Xeomin.Daxxify vs. Xeomin: which neurotoxin is right for you?

NewsXeomin identified as competitor of AbbVie on Jan 1st '11.The FDA approved Xeomin, a botulinum toxin that competes with AbbVie's Botox, in 2011, but efforts to promote the drug have ramped up in recent years.

NewsVogue partners with Xeomin.The party promoted Vogue's SmartTox partnership with Xeomin, a prescription medicine that is injected into muscles in order to improve the look of frown lines.